Fri, Aug 22, 2014, 3:30 AM EDT - U.S. Markets open in 6 hrs.

Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • stultss2011 stultss2011 Sep 24, 2012 11:01 AM Flag

    Up .14

    Could be way off, but maybe the EU approval word is beginning to leak.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I doubt if anything has been leaked. I'm confident that they will approve, but I do not think it's a slam dunk. The FDA shot it down and I'm sure this is being looked at closely by the EMEA. Maybe it's good that Amuvatinib was canceled. We don't want bad news after good news, that seems to put the brakes on. This will mean a decrease in expenses for the 4th quarter.

      Would be nice to see the fours again.

      Sentiment: Strong Buy

      • 1 Reply to freetoquestionu
      • Free, nothing is a slam dunk but really think that Man#$2 and company think this will be approved. Went back over the Stifel Nicolaus presentation from a few weeks ago and he said "if approved, as we anticipate". Also under 2012 milesones and events, for Q3 they state "Dacogen-European Commission approval in AML expected". Tried to copy and paste below:

        SGI-110 AML/MDS Phase I completed and Phase II initiated
        AT13387 – Phase I completed
        Data presentations at AACR, ASCO and EASL
        FGFR inhibitor (Janssen) - Phase I trial started (£3.5M milestone)
        CHMP opinion issued for Dacogen in AML

        Quarter 3
        •Dacogen – European Commission approval in AML expected
        •AT13387 – Initiate additional Phase II solid tumor trials

        Quarter 4
        •SGI-110 – Data update from Phase 1/2 in AML/MDS at ASH
        •SGI-110 – Initiate Phase II solid tumor trials
        •AT13387 – Preliminary Phase II data in GIST
        •Amuvatinib – Phase II data in SCLC

        Also, interesting comments on GSK relationship. He said ASTX was ready for a "additional relationship and further collaboration" with GSK. Said Astex has a "basket" of drugs they are working with GSK on.

        Max

        Sentiment: Strong Buy

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.